Compound Detail
CHEMBL4802161
DALPICICLIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL4802161 |
| Name | DALPICICLIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | SGJLSPUSUBJWHO-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
2
Known Names
12
Indications
Molecular Properties
446.6
MW (Da)
4.02
ALogP
8
HBA
2
HBD
101.8
PSA (Ų)
0.57
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Breast Neoplasms Breast Neoplasms Carcinoma, Squamous Cell Esophageal Neoplasms Nasopharyngeal Carcinoma Neoplasms Ovarian Neoplasms Pancreatic Neoplasms Sarcoma Liver Diseases Melanoma Stomach Neoplasms
Activity Summary
IC50 2 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.89 | 7.82 | 13.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 13.0 | nM | 7.89 | Inhibition of CDK4/cyclin D (unknown origin) | 35485642 |
| Unchecked | IC50 | = | 18.0 | nM | 7.75 | Inhibition of CDK6/Cyclin D (unknown origin) | 35485642 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35485642 | 10.1021/acs.jmedchem.1c02064 | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine